Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 86INDUSTRY 23NIH 4OTHER_GOV 3NETWORK 3UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 63Head & Neck 53Thoracic 40Gastrointestinal 40CNS 22Genitourinary 19Sarcoma 11Lymphoid 11Other solid neoplasm 6Dermatologic 3Breast 3Plasma cell 2Other neoplasm 2Endocrine 2Classical hematology 2Tumor-Agnostic 1Other 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1

Interventions

Cyclophosphamide 42Docetaxel 33Paclitaxel 31Tamoxifen 29Doxorubicin 29Trastuzumab 25Radiotherapy 21Epirubicin 16Letrozole 15Anastrozole 12exemestane 11Fluorouracil 11Capecitabine 10Bevacizumab 10palbociclib 9Immunohistochemistry 9Fulvestrant 9Filgrastim 9Lapatinib 8Zoledronic Acid 7Methotrexate 7Magnetic Resonance Spectroscopy 7Gene Expression Profiling 7pertuzumab 6Triptorelin Pamoate 6Taxes 6Surgical Procedures, Operative 6Microarray Analysis 6Goserelin 6Chemotherapy, Adjuvant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Cisplatin × Breast × Clear all
NCT02445391 2026-06-01

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
415 enrolled 15 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00003032 2020-04-01

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

Canadian Cancer Trials Group

Phase 3 Completed
224 enrolled
Breast

Breast Neoplasms

NCT00002772 2013-01-24

S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

SWOG Cancer Research Network

Phase 3 Terminated
602 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡